tiprankstipranks
Trending News
More News >
Erika Carmel Ltd. (IL:BCUR)
:BCUR
Israel Market
Advertisement

Erika B-Cure (BCUR) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Erika B-Cure has a market cap or net worth of 28.85M. The enterprise value is 27.34M.
Market Cap28.85M
Enterprise Value27.34M

Share Statistics

Erika B-Cure has 104,165,290 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding104,165,290
Owned by Insiders
Owned by Institutions

Financial Efficiency

Erika B-Cure’s return on equity (ROE) is -0.63 and return on invested capital (ROIC) is -46.49%.
Return on Equity (ROE)-0.63
Return on Assets (ROA)-0.27
Return on Invested Capital (ROIC)-46.49%
Return on Capital Employed (ROCE)-0.56
Revenue Per Employee949.02K
Profits Per Employee-236.75K
Employee Count40
Asset Turnover1.09
Inventory Turnover0.73

Valuation Ratios

The current PE Ratio of {name} is {pe}. {name}’s PEG ratio is {priceToEarningsGrowthRatio}.
PE Ratio
PS Ratio0.00
PB Ratio1.73
Price to Fair Value1.61
Price to FCF-0.16
Price to Operating Cash Flow-0.17
PEG Ratio-0.03

Income Statement

In the last 12 months, Erika B-Cure had revenue of 37.96M and earned -9.47M in profits. Earnings per share was -0.09.
Revenue37.96M
Gross Profit26.05M
Operating Income-9.93M
Pretax Income-10.51M
Net Income-9.47M
EBITDA-8.30M
Earnings Per Share (EPS)-0.09

Cash Flow

In the last 12 months, operating cash flow was -4.22M and capital expenditures -94.00K, giving a free cash flow of -4.32M billion.
Operating Cash Flow-4.22M
Free Cash Flow-4.32M
Free Cash Flow per Share-0.04

Dividends & Yields

Erika B-Cure pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.65
52-Week Price Change-19.48%
50-Day Moving Average22.86
200-Day Moving Average22.59
Relative Strength Index (RSI)73.91
Average Volume (3m)120.98K

Important Dates

Erika B-Cure upcoming earnings date is ―, ―.
Last Earnings Date
Next Earnings Date
Ex-Dividend Date

Financial Position

Erika B-Cure as a current ratio of 1.64, with Debt / Equity ratio of 20.58%
Current Ratio1.64
Quick Ratio0.66
Debt to Market Cap<0.01
Net Debt to EBITDA-0.16
Interest Coverage Ratio-39.08

Taxes

In the past 12 months, Erika B-Cure has paid -1.04M in taxes.
Income Tax-1.04M
Effective Tax Rate0.10

Enterprise Valuation

Erika B-Cure EV to EBITDA ratio is -3.08, with an EV/FCF ratio of -5.92.
EV to Sales0.67
EV to EBITDA-3.08
EV to Free Cash Flow-5.92
EV to Operating Cash Flow-6.05

Balance Sheet

Erika B-Cure has 4.15M in cash and marketable securities with 3.09M in debt, giving a net cash position of -1.05M billion.
Cash & Marketable Securities4.15M
Total Debt3.09M
Net Cash-1.05M
Net Cash Per Share-0.01
Tangible Book Value Per Share0.14

Margins

Gross margin is 75.96%, with operating margin of -26.15%, and net profit margin of -24.95%.
Gross Margin75.96%
Operating Margin-26.15%
Pretax Margin-27.70%
Net Profit Margin-24.95%
EBITDA Margin-21.86%
EBIT Margin-27.03%

Analyst Forecast

The average price target for Erika B-Cure is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target
Price Target Upside
Analyst Consensus
Analyst Count0
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis